Analysis of Regulation of FOXP3 expression and induction of regulatory T cells for therapeutic application to autoimmune diseases.
Analysis of Regulation of FOXP3 expression and induction of regulatory T cells for therapeutic application to autoimmune diseases.
批准号:
16591002
负责人:
SAITO Kazuyoshi
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
最近的研究强调了具有调节/抑制特性的T细胞在控制自身免疫性疾病中的重要性。CD4(+)CD25(+)调节性T(T(Reg))细胞在维持外周免疫耐受和预防自身免疫中发挥重要作用。1.探讨类风湿关节炎(RA)和系统性红斑狼疮(SLE)患者外周血中CD4(+)CD25(+)T(Reg)细胞或FOXP3阳性细胞的特征。分析RA、SLE和正常人外周血中CD4(+)CD25(+)T细胞和FOXP3阳性细胞的频率和表型。类风湿关节炎和系统性红斑狼疮患者外周血中表达CD25和FOP3的CD4+T细胞的频率明显低于健康献血者。2.用脂质体转染法将FOXP3表达载体导入COST细胞,用核受体技术将FOXP3表达载体导入外周血淋巴细胞。用Western blotting和FACScan分析证实FOXP3蛋白在两种细胞中的表达。3.研究细胞因子和病毒蛋白对FOXP3基因表达的影响。我们将FOXP3表达载体和荧光素酶报告载体共转染到FOXP3表达载体和荧光素酶报告载体上,利用核受体将FOXP3结合序列的3次串联连接到外周血淋巴细胞。即使在IL-1、2、4、6和肿瘤坏死因子存在的情况下,共转染FOXP3也不能诱导荧光素酶活性。共转染TAX p40或CMV E1+2表达载体不能增加荧光素酶的活性。
英文摘要
Recent studies have emphasized the importance of T cells with regulatory/suppressor properties in controlling autoimmune diseases. CD4(+) CD25(+) regulatory T(T(reg)) cells play a critical role in the maintenance of peripheral tolerance and the prevention of autoimmunity. We developed anti-FOXP3 polyclonal and employed western blotting analysis and flowcytometric analysis using mononuclear cells from autoimmune diseases.1.We have explored the characteristics of CD4(+) CD25(+) T(reg) cells or FOXP3 positive cells in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The frequency and phenotype of CD4(+) CD25(+) T cells as well as FOXP3 positive cells in peripheral blood (PB) from patients with RA, SLE and PBMC from normal controls were analyzed. An decreased frequency of CD4+ T cells expressing CD25 or FOP3 were detected in PB from patients with RA and SLE compared with that in healthy donor.2.We transfected FOXP3 expression vectors to COST cells by lipofection and peripheral lymphocytes using nucleofector. Then expression of FOXP3 protein in both cells were confirmed by western blotting as well as by FACScan analysis.3.We also investigate the effect of cytokines or viral protein including human T lymphocytic leukemia virus tax p40 and cytomegalovirus early antigen-on expression of FOXP3 gene. We co-transfecto FOXP3 expression vector and luciferase reporter vector, which was ligated with 3 times tandem repeats of FOXP3 binding sequences to peripheral lymphocytes using nucleofector. Co-transfection of FOXP3 did not induce luciferase activities even in the presence of cytokines including IL-1,2,4,6 and TNF. Co-transfection of Tax p40 or CMV E1+2 expression vector did not increase of luciferase activities.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Glucocorticoid inhibits the human pro-interleukin 1beta gene (ILIB) by decreasing DNA binding of transactivators to the signal responsiveenhancer.
糖皮质激素通过减少反式激活因子与信号反应增强子的 DNA 结合来抑制人白细胞介素 1β 基因 (ILIB)。
DOI:
--
发表时间:
2006
期刊:
Mol Immunol 43巻7号
影响因子:
--
作者:
[Fujii, Y.et al., Waterman WR]
通讯作者:
Waterman WR
DOI:
10.1016/j.clim.2006.01.001
发表时间:
2006-06-01
期刊:
CLINICAL IMMUNOLOGY
影响因子:
8.6
作者:
[Fujii, Yuko, Fujii, Koichi, Tanaka, Yoshiya]
通讯作者:
Tanaka, Yoshiya
Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes.
淋巴细胞中白介素2对多药耐药1基因的转录调控。
DOI:
--
发表时间:
2004
期刊:
Gene to Cells 9巻
影响因子:
--
作者:
[Tsujimura, S.]
通讯作者:
S.
DOI:
10.1093/rheumatology/keh443
发表时间:
2005-02-01
期刊:
RHEUMATOLOGY
影响因子:
5.5
作者:
[Tokunaga, M, Fujii, K, Tanaka, Y]
通讯作者:
Tanaka, Y
Glucocorticoid inhibits the human pro-interleukin 1β gene(ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer.
糖皮质激素通过减少反式激活因子与信号响应增强子的 DNA 结合来抑制人白介素原 1β 基因 (ILIB)。
DOI:
--
发表时间:
2006
期刊:
Molecular Immunology 43(7)
影响因子:
--
作者:
[Kyo, F., Futani, H., Matsui, K., et al., Wayne R.Waterman.et al.]
通讯作者:
Wayne R.Waterman.et al.
共 9 条
Novel strategies for treatment of rheumatic diseases by Wnt signal blockades
-
批准号:15K09541
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:SAITO Kazuyoshi
-
依托单位:
Involvement of Epithelial and endothelial to mesenchymal transition in tissue remolding of rheumatic diseases
-
批准号:23591451
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:SAITO Kazuyoshi
-
依托单位:
The mechanism of inflammation in autoimmune response during the acute phase of Kawasaki disease.
-
批准号:22790969
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:SAITO Kazuyoshi
-
依托单位:
A New treatment strategy using analysis of anti-transcriptional factors antibody in connective tissue diseases.
-
批准号:20591179
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:SAITO Kazuyoshi
-
依托单位:
Therapeutic strategy for inflammatory diseases by a novel negative regulatory transcriptional factor of inflammatory cytokines
-
批准号:18591128
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2006
-
负责人:SAITO Kazuyoshi
-
依托单位:
Treatment for rheumatoid arthritis with immunogene therapy by angiostatin
-
批准号:13670486
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2001
-
负责人:SAITO Kazuyoshi
-
依托单位:
Crystallographic studies on inorganic components of black-and calcium bilirubinate gallstones
-
批准号:08671478
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:SAITO Kazuyoshi
-
依托单位:
Chemical and crystallographic characteristics and growth factors of calcium carbonate gallstones.
-
批准号:02670586
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1990
-
负责人:SAITO Kazuyoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
-
批准号:82371809
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:聂红
-
依托单位:
CXCR1/HIF-1α正反馈环在调控DC细胞炎症因子分泌及自身免疫疾病中的作用及机制
-
批准号:32070768
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杜昌升
-
依托单位:
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位:
多发性硬化相关microRNA和靶基因鉴定及其对Th17和Treg细胞生成及分化的作用
-
批准号:81171120
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2011
-
负责人:付锦
-
依托单位:
癫痫发作机理的新探索- - - - munc 18蛋白的自身免疫作用
-
批准号:30470536
-
项目类别:面上项目
-
资助金额:18.0万元
-
批准年份:2004
-
负责人:杨茹
-
依托单位:
自身免疫性肝炎中新的自身抗原的鉴定、基因克隆及表达
-
批准号:30080027
-
项目类别:专项基金项目
-
资助金额:14.0万元
-
批准年份:2000
-
负责人:仲人前
-
依托单位: